Treprostinil SciPharm Sàrl (treprostinil)
- Region
- 🇪🇺 EU
- Active substance
- treprostinil
- Company
- SciPharm Sàrl
- Status
- Application withdrawn
- Therapeutic area
- Hypertension, Pulmonary
- Application
- EMEA/H/C/004847
- ATC
- B01AC21
- Official record
- www.ema.europa.eu
Indication
Treatment of chronic thromboembolic pulmonary hypertension
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Trepulmix Authorised · SciPharm Sàrl
- 🇪🇺 Orepaxam Application withdrawn · Ferrer Internacional S.A.
- 🇪🇺 Tyvaso Application withdrawn · United Therapeutics Europe Ltd
Follow Treprostinil SciPharm Sàrl
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.